Verily Health, Inc.
PrivateLast Round
Corporate Funding
Extension
Sep 9, 2026
Total Funding Raised
$3.81B
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Verily Health, Inc. is a health technology company that provides a data platform and AI-enabled solutions to accelerate research and improve care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Clinical Trials, Medical AI, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verily Health, Inc. Comparables
Compare Verily Health, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dassault Systèmes | 79% | |
| BC Platforms | 77% | |
| Innovaccer | 77% |
Verily Health, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding Extension | Sep 9, 2026 | ||||
| Corporate Funding | Mar 19, 2026 | ||||
| Grant | Apr 30, 2025 | ||||
| Corporate Funding | Sep 9, 2022 | ||||
| Corporate Funding | Dec 17, 2020 | ||||
Private Equity | Jan 3, 2019 |
Key People
Founding team and executive leadership
Verily Health, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Series X Capital | Corporate Funding |
| Temasek | Corporate Funding, Private Equity |
| Ontario Teachers' Pension Plan | Private Equity, Corporate Funding |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Silver Lake | Corporate Funding, Private Equity |
| CU Innovations | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2026
NVIDIA participated in a corporate funding round.
- Mar 19, 2026
$300M round led by Series X Capital.
Recent news
Latest coverage and updates
- signs_new_clientOct 6, 2026
Verily Life Sciences LLC signs CDC as a new client for wastewater surveillance in United States on Sep 28th '26
Verily Health, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Verily Health, Inc.'s valuation, stock price, and market status.
Is Verily Health, Inc. a public or private company?
Verily Health, Inc. is a private company.
What is the current stock price of Verily Health, Inc.?
Verily Health, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Verily Health, Inc. worth (valuation)?
Valuation information for Verily Health, Inc. is not publicly available.
Can I buy Verily Health, Inc. stock?
Verily Health, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Verily Health, Inc.'s last funding round?
Verily Health, Inc.'s most recent funding round was Series D on March 19, 2026.
Who are the main investors in Verily Health, Inc.?
Key investors in Verily Health, Inc. include Series X Capital, Temasek, Silver Lake.
Will Verily Health, Inc. IPO soon?
No public IPO plans have been announced for Verily Health, Inc..
How can I track Verily Health, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Verily Health, Inc.'s secondary market activity and sign up for updates.